WHO ICTRP trial
A Randomized, Drug-Drug Interaction Study to Assess the Safety and…
NL-OMON51149 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON51149 |
|---|---|
| Public title | A Randomized, Drug-Drug Interaction Study to Assess the Safety and Pharmacokinetics of VNRX7145 and Ceftibuten (VNRX5024) in Healthy Adult Volunteers |
| Scientific title | A Randomized, Drug-Drug Interaction Study to Assess the Safety and Pharmacokinetics of VNRX7145 and Ceftibuten (VNRX5024) in Healthy Adult Volunteers - DDI on safety of PK of VNRX-7145 and Ceftibuten (VNRX-5024) |
| Primary sponsor | Venatorx Pharmaceuticals, Inc. |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | The Netherlands |
| Conditions | Serious infections;10004018;Serious infections |
| Interventions | Part 1 Treatment name | Treatment | How often Treatment 1A | VNRX-7145 500 mg | once Treatment 1B | Ceftibuten 400 mg | once Treatment 1C | VNRX-7145 500 mg and Ceftibuten 400 mg | once Part 2 and 3 Treatment name | Day | Treatment | How… |
| Registration date | Jul 6, 2021 |
| Target size | 54 |
| Secondary IDs | 2021-001566-37;NL77461.056.21 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: